According to the Economic Daily, on the morning of May 30th, the second National Innovation Award Commendation and Award Conference jointly organized by Ministry of Human Resources and Social Security, China Association for Science and Technology, Ministry of Science and Technology and the State Council State-owned Assets Supervision and Administration Commission was held in Beijing China Science and Technology Museum. The theme of this commendation meeting is "Science and Technology for the People, Struggle for Me".

At the commendation award meeting, the third generation semiconductor (gallium nitride) innovation team and other 10 teams won the second national innovation medal; 28 comrades, including Ding Jian, Zhang Boli and Li Lanjuan, won the Second National Innovation Well-off Medal and enjoyed the treatment of provincial and ministerial level commendation and award winners; Ding Kuiling and other 258 comrades won the second National Innovation Award.

Brief introduction of Li Lanjuan

Li Lanjuan, female, Han nationality, party member, infectious disease expert, pioneer of artificial liver in China, leader of national key infectious diseases discipline, academician of China Academy of Engineering, professor and doctoral supervisor of medical department of Zhejiang University, chief physician of the First Affiliated Hospital of Zhejiang University, director of State Key Laboratory of Infectious Diseases Diagnosis and Treatment, member of high-level expert group of National Health Commission, first member of national health science expert pool, and chairman of Lan Shu International Medical College of Shu Ren University, Zhejiang Province.

Li Lanjuan 1973 graduated from the Faculty of Medicine of Zhejiang Medical University and has been engaged in the medical treatment, teaching and research of infectious diseases for more than 30 years, with remarkable achievements. 20 13 March, China scientists led by Academician Li Lanjuan made a major breakthrough in the research of H7N9 avian influenza. The paper "Human Infected with New H7N9 Avian Influenza Virus from Live Birds Market: Clinical Analysis and Virus Genome Characteristics" has been published in the world famous medical journal The Lancet.